News and blogs
20 results found.
How should coronavirus shielding guidance for blood cancer change?
As we get used to the idea that coronavirus will be with us for a long time, what do we need to know to safely relax shielding guidance? How should that change happen, and how much do we know already?
Common symptoms of coronavirus are also symptoms of blood cancer
Dr Alex Langridge (Haematology Registrar in Newcastle upon Tyne) explains the challenges of detecting blood cancer when symptoms are similar to coronavirus, and what we can do about it.
People with blood cancer now make up a bigger proportion of coronavirus intensive care patients
Our analysis shows the proportion of people in intensive care because of coronavirus – who also have blood cancer – increased between April and May.
Why are people with blood cancer being told to shield for 12 weeks?
While everyone in the UK has felt the impact of the coronavirus over the last few weeks, people with blood cancer have felt it more than most. These 115,000 people have been told not to leave their homes at all for at least 12 weeks, which is called “shielding”.
Meet Alison, our blood cancer clinical nurse specialist
Meet Alison Paterson, a blood cancer clinical nurse specialist and member of our Nurses Working Group. Find out on what it's like working on the front line during the coronavirus pandemic.
Coronavirus mental health crisis for people with blood cancer
Over half of people who are shielding from coronavirus are struggling with their mental health and nearly one in 10 say the impact is severe, our survey of people with blood cancer has found.
How is the coronarvirus affecting the blood cancer community’s mental health?
In the current climate, it’s inevitable that many people’s mental health will be affected to some extent as we’re cooped up inside and cut off from friends and family. But what impact has the coronavirus pandemic had on people affected by blood cancer specifically?
From Dine Out to Dine IN – Confessions of a Technophobe
Technophobe Maria Clarke from our Glasgow and District Branch hosts a successful virtual fundraiser.
Findings from our survey on COVID-19
We surveyed more than 3,000 people affected by blood cancer to find out their concerns about coronavirus. Here's what we found out, and what we're going to do about it.
Over a third of people with blood cancer “haven’t had shielding letter”
Our survey found that over a third of people with blood cancer who are expecting to get a letter telling them to stay at home and shield because of the coronavirus have not yet received one.
People with undiagnosed blood cancer don't know they're vulnerable to coronavirus
There are over 10,000 people with undiagnosed blood cancer who are extremely vulnerable to the coronavirus, but don't know it.
Could a blood cancer drug be used to help people with COVID-19?
Calquence is being trialled in patients with COVID-19 who are critically ill, in the hope that it may reduce damage to their lungs.
Five charities call for supermarkets to sign up to key pledges
We've written to supermarkets with six key pledges, to ensure people with blood cancer and other vulnerable people shielding for 12 weeks can get food deliveries.
Call for supermarkets to prioritise people with blood cancer for online orders
We've written to the government and six major supermarkets, calling on them to take urgent action to make sure people with blood cancer can get food deliveries.
It's not a big day today, but it's been a big couple of years
When I joined this organisation, I said we never would change our name, writes our CEO Gemma Peters
Our new name
As of today, we have changed our name from Bloodwise to Blood Cancer UK.
Charities keep people well - we need government help too
The coronavirus emergency has increased demand for the third sector, while crushing its ability to raise funds, writes our CEO Gemma Peters.
Leukaemia protective role of Y chromosome gene discovered
Scientists funded by Bloodwise have discovered the first leukaemia protective gene that is specific to the male-only Y chromosome. Researchers at the Wellcome Sanger Institute and the University of Cambridge found that this Y-chromosome gene protects against the development of acute myeloid leukaemia (AML) and other cancers.
What causes leukaemia and how can we use this information to better treat it?
How does the immune system recognise and destroy Hodgkin lymphoma?
In Hodgkin lymphoma, the cells which are the root cause of the cancer are hidden within a much larger number of white blood cells. These white blood cells are usually very good at killing cancer cells, but may be unable to kill all of the Hodgkin lymphoma cells. Bloodwise Visiting Fellow Dr Zumla Cader has been investigating why...